Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population

Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population

ABSTRACT Aims/Introduction Leukocyte cell‐derived chemotaxin 2 (LECT2) is an obesity‐associated hepatokine that causes skeletal muscle insulin resistance. Since LECT2 is up‐regulated by the inactivation of the energy sensor AMPK in the liver, we hypothesized that LECT2 has potential as a biomarker f...

Full description

Saved in:
Bibliographic Details
Main Authors: Keita Suzuki, Hiromasa Tsujiguchi, Akinori Hara, Yumie Takeshita, Hisanori Goto, Yujiro Nakano, Reina Yamamoto, Hiroaki Takayama, Atsushi Tajima, Tatsuya Yamashita, Masao Honda, Hiroyuki Nakamura, Toshinari Takamura
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of Diabetes Investigation
Subjects:
Insulin resistance
LECT2
MASLD
Online Access:https://doi.org/10.1111/jdi.14351
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/jdi.14351

Similar Items